Main Content start here
Main Layout
Report Description

Report Description

The global cell free RNA isolation & extraction kits market is anticipated to observe impressive growth during the forecast period, 2023-2027. The major factors include rising incidences of different types of cancer, and growing number of cases with prenatal complications, are bolstering the growth of the market. The cell-free RNA isolation and extraction kits market is a well-established market with an integral part of medical decision-making, which aid in obtaining information for a wide range of treatment dissemination, emphasizing their cruciality in healthcare. The other factors supporting the market’s growth are rising geriatric population base, extensive research and development, awareness among patient population about non-invasive and minimally invasive methods, increasing government investments, and technological advancements. Also, strategic partnerships and collaborations by biotechnology and pharmaceutical companies are fueling the growth of the market.

Increasing Incidence of Cancer

The growing occurrences of cancer such as lung cancer, cervical cancer, breast cancer, and others among population, is a contributing factor for the growth of the market. Cancer is considered as second largest cause of mortality and disability across the globe. Cell-free RNA occurs in cell-free fluids and is an opportunity to detect tumors in patients with lower tumor shedding rates. For instance, in 2020, a data was released by the International Agency for Research on Cancer (IARC) which revealed that 1 in 5 people develops cancer in their lifetime, and 1 in 8 men and 1 in 11 women die from cancer, globally. As per its revised GLOBOCAN 2020 report, roughly 19.3 million new cancer cases were registered, and 10 million people died from it across the globe. Thus, the increase in number of patients suffering from cancer is bolstering the growth of the Cell Free RNA Isolation & Extraction Kits Market.

Increasing Number of Cases with Prenatal Complications

Over the past few years, rapid advancements are made in the application of non-invasive techniques such as cell-free RNA, which helps to predict the prenatal complications. Prenatal complications such as intrauterine growth restriction (IUGR), preeclampsia, and spontaneous preterm birth (PTB) can be characterized and predicted by cell free RNA (cf RNA). For instance, between 2014-2018, the pregnancy complications rates rose more than 16%, while childbirth complications rates rose more than 14%. Around seven out of every 1,000 pregnant women underwent gestational diabetes and preeclampsia complications, an almost 31% increase since 2014. Therefore, owing to the increase in number of women suffering from prenatal complications, the surge in demand for cell free RNA isolation and extraction kits is fueling the growth of the market.


Download Free Sample Report

Market Segmentation

The global cell free RNA isolation & extraction kits market is segmented into application, end user, and company. Based on application, the market is divided into oncology, prenatal screening, metabolic disorders, and others. Based on end user, the market is segmented into hospitals & clinics, pharmaceutical & biotechnology companies, and others. In terms of country, the United States is expected to be a lucrative market in the forecast period due to rising prevalence of cancer in the country.

Market Players

F.Hoffmann-La Roche AG, JBS Science Inc., Aline Biosciences, Apostle Inc. (Apostle Sciences), Danagen-Bioted, S.L., Norgen Biotek Corp., PerkinElmer, Inc., Promega Corporation, QIAGEN N.V., and Thermo Fisher Scientific Inc. are some of the leading companies operating in the market.

Attribute

Details

Base Year

2021

Historic Data

2017 – 2020

Estimated Year

2022

Forecast Period

2023 – 2027

Quantitative Units

Revenue in USD Million, and CAGR for 2017-2021 and 2022-2027

Report coverage

Revenue forecast, Volume forecast company share, competitive landscape, growth factors, and trends

Segments covered

·         Application

·         End User

·         Company

Regional scope

North America; Asia Pacific; Europe & CIS; South America; Middle East & Africa

Country scope

United States; Canada; Mexico; China; India; Japan; South Korea; Germany; France; United Kingdom; Spain; Italy; Brazil; Argentina; Colombia; South Africa; UAE; Saudi Arabia; South Africa; Turkey; Egypt; Australia;

Key companies profiled

F.Hoffmann-La Roche AG, JBS Science Inc., Aline Biosciences, Apostle Inc. (Apostle Sciences), Danagen-Bioted, S.L., Norgen Biotek Corp., PerkinElmer, Inc., Promega Corporation, QIAGEN N.V., and Thermo Fisher Scientific Inc.

Customization scope

10% free report customization with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)


Report Scope:

In this report, global cell free RNA isolation & extraction kits market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

·         Cell Free RNA Isolation & Extraction Kits Market, By Application:

    • Oncology
    • Prenatal Screening
    • Metabolic Disorders
    • Others

·         Cell Free RNA Isolation & Extraction Kits Market, By End User:

    • Hospitals & Clinics
    • Pharmaceutical & Biotechnology Companies
    • Others

·         Cell Free RNA Isolation & Extraction Kits Market, By Region:

    • North America
      • United States
      • Canada
      • Mexico
    • Asia-Pacific
      • China
      • India
      • Japan
      • Australia
      • South Korea
    • Europe & CIS
      • Germany
      • France
      • United Kingdom
      • Spain
      • Italy
    • South America
      • Brazil
      • Argentina
      • Colombia
    • Middle East & Africa

§  South Africa

§  Saudi Arabia

§  UAE

§  Egypt

§  Turkey

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in cell free RNA isolation & extraction kits market

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
Cell Free RNA Isolation & Extraction Kits Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]
Table of content

Table of content

1.    Product Overview

2.    Research Methodology

3.    Executive Summary

4.    Impact of COVID-19 on Global Cell Free RNA Isolation & Extraction Kits Market

5.    Voice of Customer

6.    Global Cell Free RNA Isolation & Extraction Kits Market Outlook

6.1.  Market Size & Forecast

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Application (Oncology, Prenatal Screening, Metabolic Disorders, Others)

6.2.2.     By End User (Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Others)

6.2.3.     By Company (2021)

6.2.4.     By Region

6.3.  Market Map

7.    North America Cell Free RNA Isolation & Extraction Kits Market Outlook

7.1.  Market Size & Forecast          

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Application

7.2.2.     By End User

7.2.3.     By Country

7.3.  North America: Country Analysis

7.3.1.     United States Cell Free RNA Isolation & Extraction Kits Market Outlook

7.3.1.1.         Market Size & Forecast

7.3.1.1.1.             By Value

7.3.1.2.         Market Share & Forecast

7.3.1.2.1.             By Application

7.3.1.2.2.             By End User

7.3.2.     Canada Cell Free RNA Isolation & Extraction Kits Market Outlook

7.3.2.1.         Market Size & Forecast

7.3.2.1.1.             By Value

7.3.2.2.         Market Share & Forecast

7.3.2.2.1.             By Application

7.3.2.2.2.             By End User

7.3.3.     Mexico Cell Free RNA Isolation & Extraction Kits Market Outlook

7.3.3.1.         Market Size & Forecast

7.3.3.1.1.             By Value

7.3.3.2.         Market Share & Forecast

7.3.3.2.1.             By Application

7.3.3.2.2.             By End User

8.    Europe Cell Free RNA Isolation & Extraction Kits Market Outlook

8.1.  Market Size & Forecast          

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Application

8.2.2.     By End User

8.2.3.     By Country

8.3.  Europe: Country Analysis

8.3.1.     France Cell Free RNA Isolation & Extraction Kits Market Outlook

8.3.1.1.         Market Size & Forecast

8.3.1.1.1.             By Value

8.3.1.2.         Market Share & Forecast

8.3.1.2.1.             By Application

8.3.1.2.2.             By End User

8.3.2.     Germany Cell Free RNA Isolation & Extraction Kits Market Outlook

8.3.2.1.         Market Size & Forecast

8.3.2.1.1.             By Value

8.3.2.2.         Market Share & Forecast

8.3.2.2.1.             By Application

8.3.2.2.2.             By End User

8.3.3.     United Kingdom Cell Free RNA Isolation & Extraction Kits Market Outlook

8.3.3.1.         Market Size & Forecast

8.3.3.1.1.             By Value

8.3.3.2.         Market Share & Forecast

8.3.3.2.1.             By Application

8.3.3.2.2.             By End User

8.3.4.     Italy Cell Free RNA Isolation & Extraction Kits Market Outlook

8.3.4.1.         Market Size & Forecast

8.3.4.1.1.             By Value

8.3.4.2.         Market Share & Forecast

8.3.4.2.1.             By Application

8.3.4.2.2.             By End User

8.3.5.     Spain Cell Free RNA Isolation & Extraction Kits Market Outlook

8.3.5.1.         Market Size & Forecast

8.3.5.1.1.             By Value

8.3.5.2.         Market Share & Forecast

8.3.5.2.1.             By Application

8.3.5.2.2.             By End User

9.    Asia-Pacific Cell Free RNA Isolation & Extraction Kits Market Outlook

9.1.  Market Size & Forecast          

9.1.1.     By Value

9.2.  Market Share & Forecast

9.2.1.     By Application

9.2.2.     By End User

9.2.3.     By Country

9.3.  Asia-Pacific: Country Analysis

9.3.1.     China Cell Free RNA Isolation & Extraction Kits Market Outlook

9.3.1.1.         Market Size & Forecast

9.3.1.1.1.             By Value

9.3.1.2.         Market Share & Forecast

9.3.1.2.1.             By Application

9.3.1.2.2.             By End User

9.3.2.     India Cell Free RNA Isolation & Extraction Kits Market Outlook

9.3.2.1.         Market Size & Forecast

9.3.2.1.1.             By Value

9.3.2.2.         Market Share & Forecast

9.3.2.2.1.             By Application

9.3.2.2.2.             By End User

9.3.3.     Japan Cell Free RNA Isolation & Extraction Kits Market Outlook

9.3.3.1.         Market Size & Forecast

9.3.3.1.1.             By Value

9.3.3.2.         Market Share & Forecast

9.3.3.2.1.             By Application

9.3.3.2.2.             By End User

9.3.4.     South Korea Cell Free RNA Isolation & Extraction Kits Market Outlook

9.3.4.1.         Market Size & Forecast

9.3.4.1.1.             By Value

9.3.4.2.         Market Share & Forecast

9.3.4.2.1.             By Application

9.3.4.2.2.             By End User

9.3.5.     Australia Cell Free RNA Isolation & Extraction Kits Market Outlook

9.3.5.1.         Market Size & Forecast

9.3.5.1.1.             By Value

9.3.5.2.         Market Share & Forecast

9.3.5.2.1.             By Application

9.3.5.2.2.             By End User

10.  South America Cell Free RNA Isolation & Extraction Kits Market Outlook

10.1.              Market Size & Forecast

10.1.1.  By Value

10.2.              Market Share & Forecast

10.2.1.  By Application

10.2.2.  By End User

10.2.3.  By Country

10.3.              South America: Country Analysis

10.3.1.  Brazil Cell Free RNA Isolation & Extraction Kits Market Outlook

10.3.1.1.      Market Size & Forecast

10.3.1.1.1.           By Value

10.3.1.2.      Market Share & Forecast

10.3.1.2.1.           By Application

10.3.1.2.2.           By End User

10.3.2.  Argentina Cell Free RNA Isolation & Extraction Kits Market Outlook

10.3.2.1.      Market Size & Forecast

10.3.2.1.1.           By Value

10.3.2.2.      Market Share & Forecast

10.3.2.2.1.           By Application

10.3.2.2.2.           By End User

10.3.3.  Colombia Cell Free RNA Isolation & Extraction Kits Market Outlook

10.3.3.1.      Market Size & Forecast

10.3.3.1.1.           By Value

10.3.3.2.      Market Share & Forecast

10.3.3.2.1.           By Application

10.3.3.2.2.           By End User

11.  Middle East and Africa Cell Free RNA Isolation & Extraction Kits Market Outlook

11.1.              Market Size & Forecast

11.1.1.  By Value

11.2.              Market Share & Forecast

11.2.1.  By Application

11.2.2.  By End User

11.2.3.  By Country

11.3.              MEA: Country Analysis

11.3.1.  South Africa Cell Free RNA Isolation & Extraction Kits Market Outlook

11.3.1.1.      Market Size & Forecast

11.3.1.1.1.           By Value

11.3.1.2.      Market Share & Forecast

11.3.1.2.1.           By Application

11.3.1.2.2.           By End User

11.3.2.  Saudi Arabia Cell Free RNA Isolation & Extraction Kits Market Outlook

11.3.2.1.      Market Size & Forecast

11.3.2.1.1.           By Value

11.3.2.2.      Market Share & Forecast

11.3.2.2.1.           By Application

11.3.2.2.2.           By End User

11.3.3.  UAE Cell Free RNA Isolation & Extraction Kits Market Outlook

11.3.3.1.      Market Size & Forecast

11.3.3.1.1.           By Value

11.3.3.2.      Market Share & Forecast

11.3.3.2.1.           By Application

11.3.3.2.2.           By End User

11.3.4.  Turkey Cell Free RNA Isolation & Extraction Kits Market Outlook

11.3.4.1.      Market Size & Forecast

11.3.4.1.1.           By Value

11.3.4.2.      Market Share & Forecast

11.3.4.2.1.           By Application

11.3.4.2.2.           By End User

11.3.5.  Egypt Cell Free RNA Isolation & Extraction Kits Market Outlook

11.3.5.1.      Market Size & Forecast

11.3.5.1.1.           By Value

11.3.5.2.      Market Share & Forecast

11.3.5.2.1.           By Application

11.3.5.2.2.           By End User

12.  Market Dynamics

12.1.              Drivers

12.2.              Challenges

13.  Market Trends & Developments

14.  Competitive Landscape

14.1.              F.Hoffmann-La Roche AG

14.2.              JBS Science Inc.

14.3.              Aline Biosciences

14.4.              Apostle Inc. (Apostle Sciences)

14.5.              Danagen-Bioted, S.L.

14.6.              Norgen Biotek Corp.

14.7.              PerkinElmer, Inc.

14.8.              Promega Corporation

14.9.              QIAGEN N.V.

14.10.            Thermo Fisher Scientific Inc.

15.          Strategic Recommendations

Figures and Tables

Frequently asked questions

Frequently asked questions

Growing incidences of various types of cancer and rising number of cases of prenatal complications are driving the demand for the global cell free RNA isolation & extraction kits market.

F.Hoffmann-La Roche AG, JBS Science Inc., Aline Biosciences, Apostle Inc. (Apostle Sciences), Danagen-Bioted, S.L., Norgen Biotek Corp., PerkinElmer, Inc., Promega Corporation, QIAGEN N.V., and Thermo Fisher Scientific Inc. are the key players operating in the global cell free RNA isolation & extraction kits market.

The lack of skilled professionals and awareness related to cell-free RNA methods and ethical, legal, and social issues related with prenatal screening can hamper the growth of the global cell free RNA isolation & extraction kits market.

The Global Cell Free RNA Isolation & Extraction Kits Market is studied from 2017 to 2027.

Related Reports